Insights

NeuroInterface Growth The company offers NeuroNode CHI systems and expanding accessories like NeuroStrip and Oskol 2 through collaborations, indicating a growing product ecosystem ready for upsell opportunities to existing customers seeking enhanced communication and control capabilities.

Strategic Partnerships Recent partnerships with IRISBOND to distribute Oskol 2 on iPad Air suggest a channel expansion strategy that can be leveraged to enter new markets or verticals via distributor and collaboration deals.

Executive Talent Addition of a high‑profile Non-Executive Director and strategic advisor signals board‑level focus on strategic growth and neuroelectric signal technology, opening doors for investor and enterprise collaborations and credibility with potential customers.

Product Portfolio Launch of new products and vocabulary pagesets like The Block expands accessibility features and accommodates users with visual impairments, presenting cross‑selling potential to clinics, hospitals, and schools needing integrated AAC solutions.

Market Position Revenue range and recent conference participation indicate a mid‑market focus with growth potential; prioritize outreach to mid‑sized healthcare providers, rehab centers, and special education institutions seeking scalable AAC and assistive technology solutions.

Similar companies to Control Bionics (ASX:CBL)

Control Bionics (ASX:CBL) Tech Stack

Control Bionics (ASX:CBL) uses 8 technology products and services including HubSpot Analytics, Linkedin Insight Tag, Amazon Web Services, and more. Explore Control Bionics (ASX:CBL)'s tech stack below.

Media & News

Control Bionics (ASX:CBL)'s Email Address Formats

Control Bionics (ASX:CBL) uses at least 4 email formats:
Control Bionics (ASX:CBL) Email FormatsExamplePercentage
FirstLast@controlbionics.comJohnDoe@controlbionics.com
68%
FLast@controlbionics.comJDoe@controlbionics.com
14%
Last@controlbionics.comDoe@controlbionics.com
11%
FirLast@controlbionics.comJohDoe@controlbionics.com
7%

Frequently Asked Questions

What is Control Bionics (ASX:CBL)'s official website and social media links?

Minus sign iconPlus sign icon
Control Bionics (ASX:CBL)'s official website is controlbionics.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Control Bionics (ASX:CBL) generate?

Minus sign iconPlus sign icon
As of August 2026, Control Bionics (ASX:CBL)'s annual revenue is estimated to be $1M - $10M.

What is Control Bionics (ASX:CBL)'s NAICS code?

Minus sign iconPlus sign icon
Control Bionics (ASX:CBL)'s NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Control Bionics (ASX:CBL) have currently?

Minus sign iconPlus sign icon
As of August 2026, Control Bionics (ASX:CBL) has approximately 42 employees across 2 continents, including Oceania and North America. Key team members include Chief Executive Officer: J. S., Chief Financial Officer: S. B. and Head Of Sales: A. A. Explore Control Bionics (ASX:CBL)'s employee directory with LeadIQ.

What industry does Control Bionics (ASX:CBL) belong to?

Minus sign iconPlus sign icon
Control Bionics (ASX:CBL) operates in the Medical Equipment Manufacturing industry.

What technology does Control Bionics (ASX:CBL) use?

Minus sign iconPlus sign icon
Control Bionics (ASX:CBL)'s tech stack includes HubSpot Analytics, Linkedin Insight Tag, Amazon Web Services, WordPress, Shopify, Microsoft 365, Google Cloud and Pardot.

What is Control Bionics (ASX:CBL)'s email format?

Minus sign iconPlus sign icon
Control Bionics (ASX:CBL)'s email format typically follows the pattern of FirstLast@controlbionics.com. Find more Control Bionics (ASX:CBL) email formats with LeadIQ.

How much funding has Control Bionics (ASX:CBL) raised to date?

Minus sign iconPlus sign icon
As of August 2026, Control Bionics (ASX:CBL) has raised $7.1M in funding. The last funding round occurred on Jan 31, 2020 for $1.7M.

When was Control Bionics (ASX:CBL) founded?

Minus sign iconPlus sign icon
Control Bionics (ASX:CBL) was founded in 2006.
Control Bionics (ASX:CBL) logo

Control Bionics (ASX:CBL)

Medical Equipment ManufacturingVictoria, Australia11-50 Employees

Control Bionics is a medical equipment manufacturer based in Melbourne, Victoria. The company develops dedicated speech generating devices and AAC accessories aimed at giving people with complex communication and physical needs a voice. Its NeuroNode platform is described as a sixth-generation computer-human-interface designed to help users communicate through text, text-to-speech, messaging, emails, and internet access, while also enabling control of entertainment and productivity tasks.
The company serves individuals with significant communication and mobility challenges and operates within the medical equipment sector offering devices and accessories to support communication and daily activities. In May 2026, it announced the appointment of Professor Nicholas Opie as a non-executive director and strategic advisor.

Section iconCompany Overview

NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2006
Employees
11-50

Section iconFunding & Financials

  • $7.1M

    Control Bionics (ASX:CBL) has raised a total of $7.1M of funding over 4 rounds. Their latest funding round was raised on Jan 31, 2020 in the amount of $1.7M as a Series B.

  • $1M - $10M

    Control Bionics (ASX:CBL)'s revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.